mhurhangee/ep-ind-claims huggingface dataset:
Hard material layer deposited as an arc PVD function layer on a workpiece, with incompletely reacted conglomerates which form metallic components in the layer, wherein the functional layer comprises a layer which is formed as an electrically isolating oxide of at least one of the metals (Me) from the transition metals of the subgroups IV, V, VI of the periodic system of elements and Al, Si, Fe, Co, Ni, Y, wherein the function layer has a content of noble gas of less than 2%, characterized in that function layer is formed as a multilayer system and a further layer is arranged between function layer and workpiece, forming an intermediate layer, particularly an adhesion layer, comprising preferably one of the metals from subgroups IV, V and VI of the periodic system of elements and/or Al, Si, Fe, Co, Ni, Y, or a mixture thereof.
A method for producing a droplet particle, comprising: (a) producing a droplet having a diameter of less than 100 um by atomizing a mixed solution, the mixed solution comprising a liquid which evaporates under a condition of gas or vacuum, a target component substance, and a surfactant having a lower concentration than a critical micelle concentration, under the condition; and (b) reducing a diameter of the droplet by evaporating the liquid during a suspending transportation of the droplet and thereby concentrating the target component substance, and forming a membrane which suppresses evaporation of the liquid, by aligning molecules of the surfactant as an inverse micelle-like structure through self-aggregation on an entire surface of a droplet with a reduced diameter to produce a droplet particle, whereby a concentration of the surfactant in the droplet particle exceeds the critical micelle concentration, and the droplet particle has a spherical shape and the droplet particle has a diameter of 10 μm or less depending on the concentration of the surfactant in the mixed solution, (c) under the condition, the droplet particle being able to be suspended and transported to a predetermined part to be reached without contacting other objects. (a) producing a droplet having a diameter of less than 100 um by atomizing a mixed solution, the mixed solution comprising a liquid which evaporates under a condition of gas or vacuum, a target component substance, and a surfactant having a lower concentration than a critical micelle concentration, under the condition; and a liquid which evaporates under a condition of gas or vacuum, a target component substance, and a surfactant having a lower concentration than a critical micelle concentration, under the condition; and (b) reducing a diameter of the droplet by evaporating the liquid during a suspending transportation of the droplet and thereby concentrating the target component substance, and forming a membrane which suppresses evaporation of the liquid, by aligning molecules of the surfactant as an inverse micelle-like structure through self-aggregation on an entire surface of a droplet with a reduced diameter to produce a droplet particle, whereby a concentration of the surfactant in the droplet particle exceeds the critical micelle concentration, and the droplet particle has a spherical shape and the droplet particle has a diameter of 10 μm or less depending on the concentration of the surfactant in the mixed solution, (c) under the condition, the droplet particle being able to be suspended and transported to a predetermined part to be reached without contacting other objects.
Particle accelerator, - wherein the particle accelerator has an evacuated accelerator cell for a particle beam of the particle accelerator, - wherein the particle accelerator has at least one electrode structure, at which a high voltage acting on the particle beam is present during operation of the particle accelerator, - wherein the particle accelerator has a voltage multiplier, to which AC voltage is supplied and which generates the high voltage present at the electrode structure during operation of the particle accelerator, - wherein the at least one electrode structure and the voltage multiplier are arranged within the evacuated accelerator cell, characterized in that the AC voltage for supplying the voltage multiplier is generated within the accelerator cell. - wherein the particle accelerator has an evacuated accelerator cell for a particle beam of the particle accelerator, - wherein the particle accelerator has at least one electrode structure, at which a high voltage acting on the particle beam is present during operation of the particle accelerator, - wherein the particle accelerator has a voltage multiplier, to which AC voltage is supplied and which generates the high voltage present at the electrode structure during operation of the particle accelerator, - wherein the at least one electrode structure and the voltage multiplier are arranged within the evacuated accelerator cell,
A regulated proportional three-way valve unit with a valve group comprising two single valves, an actuating device that actuates the single valves of the valve group, and a regulating unit acting on the actuating device and having a control-signal input, with the following features; the single valves of the valve group are constructed as two poppet valves (24, 25) disposed opposite one another with valve spindles (28, 29) that can move in opposite directions; the two valve spindles (28, 29) are biased in mutually opposite directions by means of a biasing device, specifically in such a way that a first of the poppet valves is opened and the second poppet valve is closed while the actuating device is inactive; a valve chamber of the first poppet valve and a valve chamber of the second poppet valve are in communication together with a first of the three ports of the valve unit; the actuating device has an actuator, which is common to both poppet valves (24, 25) and acts on both valve spindles (28, 29), and which, depending on its pressurization, changes the position of the valve spindles against the action of the biasing device; characterized in that the actuating device and the biasing device are matched to one another in such a way that, during steady changes of the input variable fed to the actuating device from a first operating value to a second operating value in a manner offset relative to one another, the first poppet valve is closed progressively over its entire operating travel at first and only then is the second poppet valve opened progressively over its entire operating travel; a sensor (43, 47) supplies a signal, which corresponds to the relative distance of the two valve spindles (28, 29) from one another and is fed back to the regulating unit.
An infusion system, comprising: an infusion set, comprising an inner hub which comprises at least one needle and an outer hub wherein at least one of said inner hub and said outer hub is releasably secured by an inserter; and the inserter comprising an inserter button; and a spring; wherein said inserter button is configured to release said spring and drive said infusion set for placement at an infusion site; characterised in that, activation of said inserter button sequentially compresses said spring and releases said spring to trigger said inserter, and further comprising: a hammer disposed at an end of said spring and configured for release by movement of said inserter button; and a table rotationally secured to said inner hub and configured to be struck by said hammer. an infusion set, comprising an inner hub which comprises at least one needle and an outer hub wherein at least one of said inner hub and said outer hub is releasably secured by an inserter; and the inserter comprising an inserter button; and a spring; wherein an inserter button; and a spring; wherein said inserter button is configured to release said spring and drive said infusion set for placement at an infusion site; characterised in that, activation of said inserter button sequentially compresses said spring and releases said spring to trigger said inserter, and further comprising: a hammer disposed at an end of said spring and configured for release by movement of said inserter button; and a table rotationally secured to said inner hub and configured to be struck by said hammer. a hammer disposed at an end of said spring and configured for release by movement of said inserter button; and a table rotationally secured to said inner hub and configured to be struck by said hammer.
A valve device with a valve, the valve device comprising a flow channel in the valve; a first sensor configured to record at least one first signal indicative of local fluid velocity in the flow channel; a second sensor configured to record at least one second signal indicative of a temperature of a fluid in the flow channel; a control unit configured to determine a flow rate through the valve based on the at least one first signal indicative of local fluid velocity and based on the at least one second signal recorded by the second sensor; characterized in that the second sensor is moveably arranged in the flow channel. a flow channel in the valve; a first sensor configured to record at least one first signal indicative of local fluid velocity in the flow channel; a second sensor configured to record at least one second signal indicative of a temperature of a fluid in the flow channel; a control unit configured to determine a flow rate through the valve based on the at least one first signal indicative of local fluid velocity and based on the at least one second signal recorded by the second sensor; characterized in that the second sensor is moveably arranged in the flow channel.
An acylated protease stabilised insulin wherein the protease stabilised insulin, formally, consists of a non-protease stabilised insulin wherein at least two hydrophobic amino acids have been substituted with hydrophilic amino acids, and wherein said substitutions are situated one, two or three amino acids away from or within two or more protease cleavage sites which are selected from positions B9-10, B10-11, B13-14, B14-15, B24-25, B25-26, A13-14 and A14-15 of the non-protease stabilised insulin and wherein such protease stabilised insulin optionally further comprises one or more additional mutations with the proviso that there is only one lysine residue in the stabilized insulin, and wherein the acyl moiety is attached to the lysine residue or to a N-terminal position in the protease stabilized insulin and has the general formula Acy-AA1 n -AA2 m -AA3 p -, wherein n is 0 or an integer in the range from 1 to 3; m is an integer in the range from 1 to 10; p is 0 or an integer in the range from 1 to 10; Acy is a fatty acid or a fatty diacid comprising from about 8 to about 24 carbon atoms; AA1 is a neutral linear or cyclic amino acid residue; AA2 is an acidic amino acid residue; AA3 is a neutral, alkyleneglycol-containing amino acid residue; the order by which AA1, AA2 and AA3 appears in the formula can be interchanged independently; AA2 can occur several times along the formula the connections between Acy, AA1, AA2 and/or AA3 are amide bonds which, formally, can be obtained by removal of a hydrogen atom or a hydroxyl group from each of Acy, AA1, AA2 and AA3; and attachment to the protease stabilised insulin can be from the C-terminal end of a AA1, AA2, or AA3 residue in the acyl moiety of the formula or from one of the side chain(s) of an AA2 residue present in the moiety of formula n is 0 or an integer in the range from 1 to 3; m is an integer in the range from 1 to 10; p is 0 or an integer in the range from 1 to 10; Acy is a fatty acid or a fatty diacid comprising from about 8 to about 24 carbon atoms; AA1 is a neutral linear or cyclic amino acid residue; AA2 is an acidic amino acid residue; AA3 is a neutral, alkyleneglycol-containing amino acid residue; the order by which AA1, AA2 and AA3 appears in the formula can be interchanged independently; AA2 can occur several times along the formula the connections between Acy, AA1, AA2 and/or AA3 are amide bonds which, formally, can be obtained by removal of a hydrogen atom or a hydroxyl group from each of Acy, AA1, AA2 and AA3; and attachment to the protease stabilised insulin can be from the C-terminal end of a AA1, AA2, or AA3 residue in the acyl moiety of the formula or from one of the side chain(s) of an AA2 residue present in the moiety of formula
A rotorcraft, comprising: a floor panel comprising seat attachment provisions, defining a plurality of seat locations; and a plurality of passenger seats coupled to the floor panel, wherein: the plurality of passenger seats comprises eighteen passenger seats; the plurality of passenger seats is arranged into five seating rows, wherein the five seating rows comprise a first seating row, a second seating row, a third seating row, a fourth seating row, and a fifth seating row; the first seating row comprises one passenger seat facing a front end of the rotorcraft; the second seating row consists of four passenger seats facing a back end of the rotorcraft; the third seating row consists of four passenger seats facing the front end of the rotorcraft; the fourth seating row consists of four passenger seats facing the back end of the rotorcraft; the fifth seating row comprises five adjacent passenger seats facing the front end of the rotorcraft; the second seating row and the third seating row face each other; and the fourth seating row and the fifth seating row face each other; wherein the floor panel comprises at least one unused seat location. a floor panel comprising seat attachment provisions, defining a plurality of seat locations; and a plurality of passenger seats coupled to the floor panel, wherein: the plurality of passenger seats comprises eighteen passenger seats; the plurality of passenger seats is arranged into five seating rows, wherein the five seating rows comprise a first seating row, a second seating row, a third seating row, a fourth seating row, and a fifth seating row; the first seating row comprises one passenger seat facing a front end of the rotorcraft; the second seating row consists of four passenger seats facing a back end of the rotorcraft; the third seating row consists of four passenger seats facing the front end of the rotorcraft; the fourth seating row consists of four passenger seats facing the back end of the rotorcraft; the fifth seating row comprises five adjacent passenger seats facing the front end of the rotorcraft; the second seating row and the third seating row face each other; and the fourth seating row and the fifth seating row face each other; the plurality of passenger seats comprises eighteen passenger seats; the plurality of passenger seats is arranged into five seating rows, wherein the five seating rows comprise a first seating row, a second seating row, a third seating row, a fourth seating row, and a fifth seating row; the first seating row comprises one passenger seat facing a front end of the rotorcraft; the second seating row consists of four passenger seats facing a back end of the rotorcraft; the third seating row consists of four passenger seats facing the front end of the rotorcraft; the fourth seating row consists of four passenger seats facing the back end of the rotorcraft; the fifth seating row comprises five adjacent passenger seats facing the front end of the rotorcraft; the second seating row and the third seating row face each other; and the fourth seating row and the fifth seating row face each other; wherein the floor panel comprises at least one unused seat location.
Device for processing at least one packaging machine (12a-e), in particular for tensioning at least one tensioning element of the packaging container (12a-e), having at least one linear axis (16a-e), having at least one pair of pivot arms (18a-e) which includes a first pivot arm (20a-e) and a second pivot arm (24a-e) which is arranged in a mirror-symmetrical manner with respect to the first pivot arm (20a-e) with reference to a symmetry axis (22a-e) which is perpendicular to the at least one linear axis (16a-e), wherein the first pivot arm (20a-e) is mounted so as to be rotatable in a first rotational movement (28a-e) about a first pivot arm rotational axis (30a-e) which is perpendicular to the symmetry axis (22a-e) and displaceable in a first displacement movement (32a-e) in the direction of the at least one linear axis (16a-e) and the second pivot arm (24a-e) is mounted so as to be rotatable in a second rotational movement (36a-e) about a second pivot arm rotational axis (38a-e) which is perpendicular to the symmetry axis (22a-e) and displaceable in a second displacement movement (40a-e) in the direction of the at least one linear axis (16a-e), and having a coupler mechanism (42a-e) which is provided for the purpose of generating the first rotational movement (28a-e) and the first displacement movement (32a-e) of the first pivot arm (20a-e) and the second rotational movement (36a-e) and the second displacement movement (40a-e) of the second pivot arm (24a-e) from at least one first drive movement (44a-e) and one second drive movement (46a-e), and wherein the first rotational movement (28a-e) and the second rotational movement (36a-e) as well as the first displacement movement (32a-e) and the second displacement movement (40a-e) are in each case synchronous with one another in opposite directions.
A flow sensor (100, 210) for determining the flow rate of a fluid therethrough, comprising: a linear chamber for the fluid to flow therethrough; a moveable magnet (170, 230) positioned within the linear chamber; a permanent stationary magnet positioned about the linear chamber; and one or more sensors positioned about the linear chamber to determine the position of the moveable magnet therein. a linear chamber for the fluid to flow therethrough; a moveable magnet (170, 230) positioned within the linear chamber; a permanent stationary magnet positioned about the linear chamber; and one or more sensors positioned about the linear chamber to determine the position of the moveable magnet therein.
A ready-to-use pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, said formulation comprising: i) from 0.005 to 0.02% w/v of buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient; ii) from 0.5 to 10% w/v of a thickening agent; iii) a buffering agent in an amount to provide a pH of 5.0-7.0; wherein said formulation has a viscosity comprised between 500 and 2300 mPas at 25 ± 2°C and the thickening agent is a water soluble cellulose derivative. i) from 0.005 to 0.02% w/v of buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient; ii) from 0.5 to 10% w/v of a thickening agent; iii) a buffering agent in an amount to provide a pH of 5.0-7.0; said formulation has a viscosity comprised between 500 and 2300 mPas at 25 ± 2°C and the thickening agent is a water soluble cellulose derivative.
An acoustic antenna intended to equip a sonar, the antenna being centred around a first longitudinal axis and comprising at least a first set of at least two transducers and a second set of at least two transducers stacked along said longitudinal axis, with each transducer having at least one radial mode having a resonant frequency, called radial frequency, as well as a cavity mode having a resonant frequency, called cavity frequency, the transducers of the first set being configured to transmit sound waves in a first continuous frequency band extending at least between the cavity frequencies and the radial frequencies of the transducers of the first set and the transducers of the second set being configured to transmit sound waves in a second continuous frequency band extending at least between the cavity frequencies and the radial frequencies of the transducers of the second set, with the cavity frequency of a transducer of the second set being substantially equal to the radial frequency of a transducer of the first set plus or minus (fr1-fc1)/10, with fr1 being the radial frequency of the transducer of the first set and fc1 being the cavity frequency of the transducer of the first set, characterised in that the transducers of the second set are placed between the transducers of the first set and in that no transducer of the first set is placed between the transducers of the second set.
A collector optical system for extreme ultraviolet and X-ray applications in which EUV or X-ray radiation from a radiation source is directed to an image focus to form a far-field intensity distribution, comprising a plurality of mirrors arranged in a nested and symmetric configuration about an optical axis that extends through the radiation source, with each mirror having at least first and second reflective surfaces (202, 204) configured to respectively successively grazingly reflect the radiation to form the far-field intensity distribution, characterised in that at least one of the first and second reflective surfaces comprises a polynomial corrective shape arranged to redirect part of the radiation incident thereon in a direction to fill dips in the far-field intensity distribution due to shadowing of the mirror thickness.
Method for processing a piece of initial data, to authorize a verification of the authenticity of a payment terminal by means of said piece of initial data, the method carrying out, within said payment terminal: - a step for obtaining at least one piece of information external to said payment terminal, called a piece of initial data, said piece of initial data being an answer to a reset transmitted by a smartcard subsequently to its insertion into the payment terminal; - a step of cryptographic processing of said piece of initial data, delivering a piece of processed data; - a step of visual and/or sound rendering of said piece of processed data. - a step for obtaining at least one piece of information external to said payment terminal, called a piece of initial data, said piece of initial data being an answer to a reset transmitted by a smartcard subsequently to its insertion into the payment terminal; - a step of cryptographic processing of said piece of initial data, delivering a piece of processed data; - a step of visual and/or sound rendering of said piece of processed data.